Bio-Hybrid Therapeutics
Hospitals and Health Care • 
Manhattan, New York, United States • 1-10 Employees
Company overview
| Headquarters | Manhattan, New York, United States |
| Website | |
| NAICS | 62 |
| Founded | 2019 |
| Employees | 1-10 |
Key Contact at Bio-Hybrid Therapeutics
J.Nicole Heitmeyer
Chief Executive Officer
About Bio-Hybrid Therapeutics
Finally, a biologic drug that treats the source of the disease and not the symptoms of Atopic Dermatitis.
$
Bio-Hybrid Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Bio-Hybrid Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Bio-Hybrid Therapeutics has never raised funding before.
United Kingdom
Spain
Frequently asked questions
Bio-Hybrid Therapeutics is located in Manhattan, New York, US.
Bio-Hybrid Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.
Bio-Hybrid Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
